PPAR-gamma agonists decrease hyperhomcysteinemia and cardiac dysfunction: new hope for ailing diabetic hearts?
Rocic
Petra
P
Rezk
Bashir
B
Lucchesi
Pamela A
PA
D000818:Animals; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D048909:Diabetes Complications / Q000503:physiopathology* / Q000517:prevention & control; D006710:Homocysteine / Q000097:blood*; D020138:Hyperhomocysteinemia / Q000503:physiopathology* / Q000517:prevention & control; D051379:Mice; D047495:PPAR gamma / Q000819:agonists* / Q000378:metabolism; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000503:physiopathology* / Q000517:prevention & control
D002316:Cardiotonic Agents; D047495:PPAR gamma; D006710:Homocysteine